Table 4.
Living donation/transplantation surgery practices and presurgical screening
| Survey question | Overall | Stratified by state COVID-19 cumulative incidence |
||
|---|---|---|---|---|
| Low | Moderate | High | ||
| Would you approve a living donor candidate for surgery based on telehealth evaluation only, without physical exam? (n = 117) | % (n) | % (n) | % (n) | % (n) |
| Yes | 17 (20) | 16 (6) | 21 (8) | 14 (6) |
| No | 83 (97) | 84 (31) | 79 (30) | 86 (36) |
| When are you planning to resume normal living donor transplantation procedures? (n = 118) | % (n) | % (n) | % (n) | % (n) |
| Never interrupted | 5 (6) | 14 (5) | 3 (1) | 0 (0) |
| Within the next 2 weeks | 31 (37) | 24 (9) | 44 (17) | 26 (11) |
| Within the month | 27 (32) | 16 (6) | 18 (7) | 45 (19) |
| When the incidence of local COVID-19 cases has shown steady decline over 14 days | 6 (7) | 5 (2) | 5 (2) | 7 (3) |
| When recommended by professional guidelines | 6 (7) | 3 (1) | 8 (3) | 7 (3) |
| Program had paused, but now resumed | 25 (29) | 38 (14) | 23 (9) | 14 (6) |
| When you resume living donation, when will you perform COVID-19 testing in asymptomatic patients in relation to surgery? (n = 116) | % (n) | % (n) | % (n) | % (n) |
| Within 24 hours | 25 (29) | 24 (9) | 29 (11) | 22 (9) |
| Within >24 to 48 hours | 48 (56) | 43 (16) | 47 (18) | 54 (22) |
| Within >48 to 72 hours | 27 (31) | 32 (12) | 24 (9) | 24 (10) |
| Will not test asymptomatic patients | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| What testing modality do you use for presurgical COVID-19 testing for living donors? Select all that apply. (n = 116) | % (n) | % (n) | % (n) | % (n) |
| PCR, nasopharyngeal swab | 99 (115) | 97 (36) | 100 (37) | 100 (42) |
| PCR, other specimen | 1 (1) | 3 (1) | 0 (0) | 0 (0) |
| Serum IgG antibody | 19 (22) | 16 (6) | 14 (5) | 26 (11) |
| Serum IgM antibody | 14 (16) | 14 (5) | 11 (4) | 17 (7) |
| Serum antigen | 2 (2) | 3 (1) | 0 (0) | 2 (1) |
| Where do you send presurgical COVID-19 testing for donors and recipients? Select all that apply. (n = 114) | % (n) | % (n) | % (n) | % (n) |
| Hospital lab | 93 (106) | 89 (31) | 95 (36) | 95 (39) |
| Community lab | 13 (15) | 17 (6) | 13 (5) | 10 (4) |
| Public health reference lab | 4 (5) | 3 (1) | 3 (1) | 7 (3) |
| How has the COVID-19 pandemic impacted kidney paired donation (KPD) at your center? (n = 116) | % (n) | % (n) | % (n) | % (n) |
| Continue all KPD | 16 (19) | 17 (6) | 18 (7) | 14 (6) |
| Continue only internal KPD | 6 (7) | 3 (1) | 8 (3) | 7 (3) |
| Halt all KPD | 72 (84) | 75 (27) | 66 (25) | 76 (32) |
| Center does not perform KPD | 5 (6) | 6 (2) | 8 (3) | 2 (1) |
COVID-19, coronavirus disease 2019; exam, examination; KPD, kidney paired donation; lab, laboratory; PCR, polymerase chain reaction.